1. In vitro assessment of colistin's antipseudomonal antimicrobial interactions with other antibiotics 
Alasdair P. MacGowan, Caroline Rynn, Mandy Wootton, Karen E. Bowker, H. Alan Holt, David S. Reeves 
Clinical Microbiology and Infection 
Volume 5, Issue 1, Pages (January 1999)
DOI: /j tb00095.x
Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions

2. Figure 1
Time kill kinetics of colistin (C) at concentration of 0.5 mg/L (0.5) and 5 mg/L (5) plus: (a) ceftazidime (CEF) at concentrations of 1 mg/L (1) and 75 mg/L (75); (b) aztreonam (AZT) at concentrations of 1 mg/L (1) and 30 mg/L (30); (c) meropenem (MER) at concentrations of 1 mg/L (1) and 25 mg/L (25); (d) piperacillin (PIP) at concentrations of 5 mg/L (5) and 100 mg/L (100); (e) gentamicin (GEN) at concentrations of 1 mg/L (1) and 10 mg/L (10); (f) ciprofloxacin (CIP) at concentrations of 0.25 mg/L (0.25) and 4 mg/L (4). GC is the growth control.
Clinical Microbiology and Infection 1999 5, 32-36DOI: ( /j tb00095.x)
Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions